Palbociclib in Patients with Head and Neck Cancer and Other Tumors with CDKN2A Alterations: Results from the Targeted Agent and Profiling Utilization Registry Study
JCO PRECISION ONCOLOGY(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined